Connect your AI

Vera Bradley VRA Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

Health CatalystHCAT

$156K-97.9%

ANI PharmaceuticalsANIP

$9.25M-46.9%

Steven MaddenSHOO

$15.27M+397%

BGSFBGSF

$249K-92.8%

TriSalus Life Sciences, Inc.TLSI

$2.74M-66.6%

KadantKAI

$2M—

Other financials

Income statement

Revenue$55.7M+7.8%

Gross profit$28.8M+26.6%

Operating income-$4.6M+74.0%

Net income-$4.8M+85.6%

EPS (diluted)-$0.17+85.8%

Balance sheet

Cash & equivalents$12.5M+10.9%

Total debt$1.1M-59.3%

Total equity$127.0M-13.0%

Total assets$219.2M-18.2%

Cash flow

Operating cash flow-$5.3M+70.7%

CapEx$333.0K-82.2%

Free cash flow-$5.6M+71.8%

Valuation

Market cap$110.62M+90.5%

Enterprise value$99.22M+100%

P/S0.4×+0.2×

Profitability

Gross margin47.9%-0.9pp

Operating margin-7.8%-2.0pp

Net margin-7%-3.0pp

FCF margin-5.8%—

Returns & leverage

Return on equity-14.1%-5.7pp

Debt / equity0×0.0×

Current ratio2.5×+0.2×

Where this comes from

Reported directly by Vera Bradley in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The official record: Vera Bradley’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Bradley's contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vera Bradley's contingent consideration liability (non-current)?: Vera Bradley (VRA) reported contingent consideration liability (non-current) of $1.84M in Q1 2026.
How has Vera Bradley's contingent consideration liability (non-current) changed year-over-year?: Vera Bradley's contingent consideration liability (non-current) decreased by 28.1% year-over-year, from $2.55M to $1.84M.